Concepedia

Publication | Open Access

Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)

DOIFull Paper Access

202

Citations

23

References

2018

Year

Christopher P. Cannon, Darren K. McGuire, Richard E. Pratley, Sam Dagogo‐Jack, James P. Mancuso, Susan Huyck, B Charbonnel, Weichung Shih, Silvina Gallo, Urszula Masiukiewicz,
American Heart Journal

Abstract

The results from the VERTIS-CV trial will define the CV and renal safety and efficacy of ertugliflozin in patients with T2DM and ASCVD.

References

YearCitations

Page 1